At the National Children's Medical Center in Shanghai, a 6-month-old infant diagnosed with a malignant testicular tumor was successfully treated using the SHURUI^® single-port surgical robot. This marked the 20th clinical procedure since the pediatric urology team at Shanghai Children's Medical Center adopted the domestically developed robotic platform earlier this year.

With just a 2.5 cm umbilical incision, the team precisely removed the tumor using snake-like instruments and 3D imaging guidance—minimizing trauma and preventing hematogenous spread. Total blood loss was under 3 ml, and the patient resumed normal activity within 24 hours.

The SHURUI^® system offers sub-millimeter precision in exceptionally narrow surgical fields. With over a dozen pediatric procedure types explored in clinical studies, the platform is shaping a China-led solution for robotic surgery in children.

Shanghai Children's Medical Center is now expanding training infrastructure and national outreach to broaden access to safer, ultra-minimally invasive care for pediatric patients.